DZ Bank has significantly reduced its holdings in Regeneron Pharmaceuticals, offloading 74.4% of its shares in Q4. Despite ...

Regeneron Pharmaceuticals won $406.8 million in damages for a lawsuit claiming Amgen violated antitrust and tort laws. A jury in a Delaware court found that Amgen violated certain laws, and gave ...

Shares of Regeneron Pharmaceuticals Inc. REGN advanced 2.39% to $584.99 Thursday, on what proved to be an all-around positive ...

Thursday closed up +0.41%, the Dow Jones Industrials Index ($DOWI) (DIA) closed up +0.65%, and the Nasdaq 100 Index ($IUXX) ...

Leading life science executives, government officials, academic leaders, and investors gather for two day off-the-record ...

Islamic law prohibits paying or receiving interest, which leads to the most ... Those principles have served investors here well: Long-term performance has been especially strong for the firm's ...

Trusted by 150+ million investors each month, your ideas have shaped the most popular finance destination.¹ Explore what you can do with news, data, and tools designed to help you make financial ...

Cryptonews has covered the cryptocurrency industry topics since 2017, aiming to provide informative insights to our readers. Our journalists and analysts have extensive experience in market analysis ...

However, throughout this time, it faced issues like lawsuits and power struggles, causing a loss of investor trust ... suggesting weak buying interest. If $0.637 support fails, further downside is ...